Hikma Pharmaceuticals unveils vision at WEF

Hikma Pharmaceuticals provided insights on the impact of recent social, political and economic developments on growth markets in the Arab World at the World Economic Forum (WEF) which ended in the Swiss resort of Davos at the weekend.
Serving as a WEF Regional Associate for the second consecutive year, Hikma was one of 2,540 business, government, academic and civil society leaders and entrepreneurs who met this year to explore solutions for pressing international, regional and industry issues under the theme ‘The New Global Context’.
Vice Chairman, President and CEO of MENA and Emerging Markets of Hikma Pharmaceuticals, Mazen Darwazeh, took part in a discussion themed ‘Arab World Growth Markets’.
During the session, Darwazah elaborated on the economic consequences of falling oil prices, the potential of cross-sector and public-private integration as well as the need for greater investment in talent and education development.
"Public-private partnership and international cooperation are the keys to ensuring the sustainable growth of worldwide economies in the face of significant oil price shocks, geopolitical tensions and the persistent gap in scientific, technical and human skills," said Darwazeh.